

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 6.91050348 |
| 2 | chemical homeostasis within a tissue (GO:0048875) | 5.44991056 |
| 3 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.42931690 |
| 4 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.83168212 |
| 5 | drug catabolic process (GO:0042737) | 4.73389352 |
| 6 | regulation of endothelial cell differentiation (GO:0045601) | 4.71584345 |
| 7 | xenobiotic catabolic process (GO:0042178) | 4.67961131 |
| 8 | exogenous drug catabolic process (GO:0042738) | 4.53505477 |
| 9 | urate metabolic process (GO:0046415) | 4.30183427 |
| 10 | negative regulation of complement activation (GO:0045916) | 4.27894800 |
| 11 | cysteine metabolic process (GO:0006534) | 4.08887151 |
| 12 | homocysteine metabolic process (GO:0050667) | 4.06167949 |
| 13 | drug transmembrane transport (GO:0006855) | 4.03863723 |
| 14 | lysine metabolic process (GO:0006553) | 4.01962406 |
| 15 | lysine catabolic process (GO:0006554) | 4.01962406 |
| 16 | response to nitrosative stress (GO:0051409) | 3.99906026 |
| 17 | negative regulation of humoral immune response (GO:0002921) | 3.88609230 |
| 18 | epoxygenase P450 pathway (GO:0019373) | 3.84753409 |
| 19 | ethanol oxidation (GO:0006069) | 3.81376187 |
| 20 | polyol transport (GO:0015791) | 3.80554143 |
| 21 | negative regulation of protein activation cascade (GO:2000258) | 3.78960806 |
| 22 | phosphate ion transport (GO:0006817) | 3.76988621 |
| 23 | positive regulation of digestive system process (GO:0060456) | 3.74452701 |
| 24 | hormone catabolic process (GO:0042447) | 3.72589886 |
| 25 | phosphate ion transmembrane transport (GO:0035435) | 3.71236890 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.67647160 |
| 27 | L-phenylalanine catabolic process (GO:0006559) | 3.67647160 |
| 28 | blood vessel maturation (GO:0001955) | 3.63297209 |
| 29 | regulation of sequestering of triglyceride (GO:0010889) | 3.60124862 |
| 30 | L-phenylalanine metabolic process (GO:0006558) | 3.58662545 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.58662545 |
| 32 | glyoxylate metabolic process (GO:0046487) | 3.58628778 |
| 33 | lymphangiogenesis (GO:0001946) | 3.58502351 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 3.52511498 |
| 35 | myofibril assembly (GO:0030239) | 3.52366912 |
| 36 | response to mercury ion (GO:0046689) | 3.50963538 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49968862 |
| 38 | flavonoid metabolic process (GO:0009812) | 3.48392660 |
| 39 | morphogenesis of an endothelium (GO:0003159) | 3.42295119 |
| 40 | endothelial tube morphogenesis (GO:0061154) | 3.42295119 |
| 41 | regulation of vasculogenesis (GO:2001212) | 3.41837469 |
| 42 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.40893603 |
| 43 | cardiac myofibril assembly (GO:0055003) | 3.40455409 |
| 44 | induction of positive chemotaxis (GO:0050930) | 3.39067947 |
| 45 | cellular response to nitric oxide (GO:0071732) | 3.37914408 |
| 46 | cellular response to epinephrine stimulus (GO:0071872) | 3.31812286 |
| 47 | * drug metabolic process (GO:0017144) | 3.30749940 |
| 48 | fatty acid beta-oxidation (GO:0006635) | 3.30001144 |
| 49 | drug transport (GO:0015893) | 3.25991412 |
| 50 | valine metabolic process (GO:0006573) | 3.25884165 |
| 51 | peptide catabolic process (GO:0043171) | 3.25470938 |
| 52 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.24929165 |
| 53 | muscle filament sliding (GO:0030049) | 3.22776769 |
| 54 | actin-myosin filament sliding (GO:0033275) | 3.22776769 |
| 55 | renal absorption (GO:0070293) | 3.20430743 |
| 56 | transcytosis (GO:0045056) | 3.19378176 |
| 57 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.18929060 |
| 58 | alpha-linolenic acid metabolic process (GO:0036109) | 3.18696400 |
| 59 | short-chain fatty acid metabolic process (GO:0046459) | 3.17353469 |
| 60 | benzene-containing compound metabolic process (GO:0042537) | 3.16677101 |
| 61 | endocrine hormone secretion (GO:0060986) | 3.15268256 |
| 62 | aromatic amino acid family catabolic process (GO:0009074) | 3.15117769 |
| 63 | low-density lipoprotein particle clearance (GO:0034383) | 3.14076331 |
| 64 | cGMP-mediated signaling (GO:0019934) | 3.13766094 |
| 65 | fatty acid oxidation (GO:0019395) | 3.13455713 |
| 66 | response to nitric oxide (GO:0071731) | 3.12623475 |
| 67 | axonemal dynein complex assembly (GO:0070286) | 3.11812209 |
| 68 | lung vasculature development (GO:0060426) | 3.11795903 |
| 69 | cellular glucuronidation (GO:0052695) | 3.09600287 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 3.09537591 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 3.08278882 |
| 72 | glomerular filtration (GO:0003094) | 3.07731895 |
| 73 | sarcomere organization (GO:0045214) | 3.07331819 |
| 74 | complement activation, alternative pathway (GO:0006957) | 3.07227882 |
| 75 | lipid oxidation (GO:0034440) | 3.06436114 |
| 76 | response to xenobiotic stimulus (GO:0009410) | 3.06177938 |
| 77 | uronic acid metabolic process (GO:0006063) | 3.03908112 |
| 78 | glucuronate metabolic process (GO:0019585) | 3.03908112 |
| 79 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.02504136 |
| 80 | primary alcohol catabolic process (GO:0034310) | 3.02384018 |
| 81 | phenylpropanoid metabolic process (GO:0009698) | 2.99604143 |
| 82 | triglyceride catabolic process (GO:0019433) | 2.99041699 |
| 83 | lymph vessel development (GO:0001945) | 2.98925134 |
| 84 | response to epinephrine (GO:0071871) | 2.97511926 |
| 85 | ethanol metabolic process (GO:0006067) | 2.97004454 |
| 86 | fibroblast migration (GO:0010761) | 2.94389645 |
| 87 | regulation of cholesterol storage (GO:0010885) | 2.93439324 |
| 88 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.93205537 |
| 89 | glutathione derivative metabolic process (GO:1901685) | 2.92569227 |
| 90 | glutathione derivative biosynthetic process (GO:1901687) | 2.92569227 |
| 91 | quaternary ammonium group transport (GO:0015697) | 2.92176918 |
| 92 | sodium-independent organic anion transport (GO:0043252) | 2.92033847 |
| 93 | fatty acid catabolic process (GO:0009062) | 2.90387676 |
| 94 | actin-mediated cell contraction (GO:0070252) | 2.88270528 |
| 95 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.87469963 |
| 96 | cellular response to reactive nitrogen species (GO:1902170) | 2.86717580 |
| 97 | regulation of cholesterol homeostasis (GO:2000188) | 2.86136257 |
| 98 | extracellular matrix assembly (GO:0085029) | 2.84652734 |
| 99 | positive regulation of vasculogenesis (GO:2001214) | 2.84281795 |
| 100 | barbed-end actin filament capping (GO:0051016) | 2.81793516 |
| 101 | carnitine metabolic process (GO:0009437) | 2.81549388 |
| 102 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.80503954 |
| 103 | cell migration involved in heart development (GO:0060973) | 2.78834861 |
| 104 | artery development (GO:0060840) | 2.78470813 |
| 105 | regulation of complement activation (GO:0030449) | 2.77095978 |
| 106 | apoptotic cell clearance (GO:0043277) | 2.77063884 |
| 107 | monocarboxylic acid catabolic process (GO:0072329) | 2.76942401 |
| 108 | lung lobe morphogenesis (GO:0060463) | 2.76212371 |
| 109 | tricarboxylic acid metabolic process (GO:0072350) | 2.75070424 |
| 110 | respiratory gaseous exchange (GO:0007585) | 2.75002980 |
| 111 | regulation of protein activation cascade (GO:2000257) | 2.74935782 |
| 112 | fatty acid transmembrane transport (GO:1902001) | 2.72326770 |
| 113 | motile cilium assembly (GO:0044458) | 2.71979301 |
| 114 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.71181583 |
| 115 | indolalkylamine catabolic process (GO:0046218) | 2.69483314 |
| 116 | tryptophan catabolic process (GO:0006569) | 2.69483314 |
| 117 | indole-containing compound catabolic process (GO:0042436) | 2.69483314 |
| 118 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.68605497 |
| 119 | branched-chain amino acid metabolic process (GO:0009081) | 2.68357849 |
| 120 | keratan sulfate catabolic process (GO:0042340) | 2.68183346 |
| 121 | phosphate ion homeostasis (GO:0055062) | 2.67589395 |
| 122 | trivalent inorganic anion homeostasis (GO:0072506) | 2.67589395 |
| 123 | extracellular fibril organization (GO:0043206) | 2.66699148 |
| 124 | actomyosin structure organization (GO:0031032) | 2.66676421 |
| 125 | 2-oxoglutarate metabolic process (GO:0006103) | 2.65128634 |
| 126 | organic cation transport (GO:0015695) | 2.65101890 |
| 127 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.64767559 |
| 128 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.64132768 |
| 129 | negative regulation of protein localization to cell surface (GO:2000009) | 2.64040395 |
| 130 | positive regulation of p38MAPK cascade (GO:1900745) | 2.63619331 |
| 131 | bile acid biosynthetic process (GO:0006699) | 2.63213268 |
| 132 | vitamin D metabolic process (GO:0042359) | 2.62736245 |
| 133 | midgut development (GO:0007494) | 2.61992348 |
| 134 | neutral lipid catabolic process (GO:0046461) | 2.61954828 |
| 135 | acylglycerol catabolic process (GO:0046464) | 2.61954828 |
| 136 | aspartate family amino acid catabolic process (GO:0009068) | 2.61910786 |
| 137 | negative regulation of norepinephrine secretion (GO:0010700) | 2.60848630 |
| 138 | renal filtration (GO:0097205) | 2.60461148 |
| 139 | cardiac muscle contraction (GO:0060048) | 2.60093291 |
| 140 | one-carbon compound transport (GO:0019755) | 2.59358048 |
| 141 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.59030266 |
| 142 | protein carboxylation (GO:0018214) | 2.59030266 |
| 143 | tryptophan metabolic process (GO:0006568) | 2.58900043 |
| 144 | endothelial cell morphogenesis (GO:0001886) | 2.58505043 |
| 145 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.58169827 |
| 146 | excretion (GO:0007588) | 2.58137559 |
| 147 | carnitine transport (GO:0015879) | 2.57579562 |
| 148 | amino-acid betaine transport (GO:0015838) | 2.57579562 |
| 149 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.57329844 |
| 150 | L-ascorbic acid metabolic process (GO:0019852) | 2.56382894 |
| 151 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.55659371 |
| 152 | iron ion import (GO:0097286) | 2.53953876 |
| 153 | protein localization to cell surface (GO:0034394) | 2.52128420 |
| 154 | ovulation from ovarian follicle (GO:0001542) | 2.51823072 |
| 155 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.50392270 |
| 156 | complement activation (GO:0006956) | 2.47753164 |
| 157 | actin filament-based movement (GO:0030048) | 2.46359479 |
| 158 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.45441225 |
| 159 | growth hormone receptor signaling pathway (GO:0060396) | 2.42657150 |
| 160 | cell volume homeostasis (GO:0006884) | 2.41907948 |
| 161 | fibril organization (GO:0097435) | 2.41060641 |
| 162 | positive regulation of lipid storage (GO:0010884) | 2.40550810 |
| 163 | skeletal muscle adaptation (GO:0043501) | 2.40308626 |
| 164 | NADH metabolic process (GO:0006734) | 2.39270356 |
| 165 | endothelium development (GO:0003158) | 2.39152634 |
| 166 | cellular response to dexamethasone stimulus (GO:0071549) | 2.36016562 |
| 167 | cardiac muscle hypertrophy (GO:0003300) | 2.34929710 |
| 168 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.33368296 |
| 169 | positive regulation of catecholamine secretion (GO:0033605) | 2.30884816 |
| 170 | negative regulation of stress fiber assembly (GO:0051497) | 2.30764985 |
| 171 | regulation of p38MAPK cascade (GO:1900744) | 2.29779873 |
| 172 | striated muscle hypertrophy (GO:0014897) | 2.28576180 |
| 173 | complement activation, classical pathway (GO:0006958) | 2.28241246 |
| 174 | import into cell (GO:0098657) | 2.27569399 |
| 175 | cilium movement (GO:0003341) | 2.27186306 |
| 176 | primary alcohol metabolic process (GO:0034308) | 2.26211662 |
| 177 | regulation of cell communication by electrical coupling (GO:0010649) | 2.26169576 |
| 178 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.25924185 |
| 179 | heart contraction (GO:0060047) | 2.25180211 |
| 180 | heart process (GO:0003015) | 2.25180211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.10572041 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81808834 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.96475715 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.90369463 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.50360180 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.35098046 |
| 7 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.33872213 |
| 8 | * CLOCK_20551151_ChIP-Seq_293T_Human | 3.19349487 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.02949008 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.95261232 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.50124100 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.49768239 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.45912710 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.42932611 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36377822 |
| 16 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.18687648 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.17255256 |
| 18 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.06999309 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.99789196 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90397877 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.87957975 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.83783419 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72765305 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.68415148 |
| 25 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65023389 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.62484406 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.58907243 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57593405 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.56946451 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56846033 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.56318803 |
| 32 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.52796910 |
| 33 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.51771974 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.47374430 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45561255 |
| 36 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.43886687 |
| 37 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42588645 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.41875966 |
| 39 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.41875966 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41242391 |
| 41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39444526 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37000944 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35960943 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35913488 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33302136 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32116470 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31331703 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30673801 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28808478 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28199745 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28199745 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27392358 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26491891 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.25198526 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24697029 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23535545 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23064637 |
| 58 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.22578153 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20114464 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15411731 |
| 61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.15303565 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15293935 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15166157 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15092299 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13082374 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12724243 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10675443 |
| 68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10636985 |
| 69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10351668 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10297254 |
| 71 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08873591 |
| 72 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.08526723 |
| 73 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.08489175 |
| 74 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08130071 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06982045 |
| 76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06156708 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05172681 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02384909 |
| 79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01752291 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01572405 |
| 81 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01489323 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01440570 |
| 83 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00556688 |
| 84 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98635121 |
| 85 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98635121 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98234044 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97686037 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97251218 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96399523 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96012140 |
| 91 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94513232 |
| 92 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94017529 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93399463 |
| 94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92763754 |
| 95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92763754 |
| 96 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92083748 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91792790 |
| 98 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91579982 |
| 99 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.91266678 |
| 100 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91169035 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91134273 |
| 102 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90929226 |
| 103 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.90736054 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90502466 |
| 105 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88415826 |
| 106 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87642458 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87014959 |
| 108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86283818 |
| 109 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86254506 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85996802 |
| 111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85881054 |
| 112 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85791158 |
| 113 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85059918 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.84677838 |
| 115 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84365995 |
| 116 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.83754868 |
| 117 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83568793 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83153534 |
| 119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82879426 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82572363 |
| 121 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82343184 |
| 122 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81713988 |
| 123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.81390029 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80301762 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78940316 |
| 126 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.78423757 |
| 127 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.77175457 |
| 128 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.77090391 |
| 129 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77016536 |
| 130 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.76565902 |
| 131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75712791 |
| 132 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.74639348 |
| 133 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72677519 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71716436 |
| 135 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.71640103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 5.39750925 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.82733512 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 4.47413312 |
| 4 | MP0005360_urolithiasis | 4.34765933 |
| 5 | MP0001958_emphysema | 3.68091933 |
| 6 | MP0010368_abnormal_lymphatic_system | 3.62639013 |
| 7 | MP0005365_abnormal_bile_salt | 2.94601579 |
| 8 | MP0004782_abnormal_surfactant_physiolog | 2.93162863 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.85440385 |
| 10 | MP0000751_myopathy | 2.82418570 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.78699786 |
| 12 | MP0001879_abnormal_lymphatic_vessel | 2.67704368 |
| 13 | MP0003252_abnormal_bile_duct | 2.52099956 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.46784301 |
| 15 | MP0003724_increased_susceptibility_to | 2.43697899 |
| 16 | MP0005332_abnormal_amino_acid | 2.38839223 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.33907746 |
| 18 | MP0004215_abnormal_myocardial_fiber | 2.30025607 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.26328900 |
| 20 | MP0005083_abnormal_biliary_tract | 2.04107215 |
| 21 | MP0009643_abnormal_urine_homeostasis | 2.00178623 |
| 22 | MP0004043_abnormal_pH_regulation | 1.97300785 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.93312562 |
| 24 | MP0001542_abnormal_bone_strength | 1.88695443 |
| 25 | MP0004272_abnormal_basement_membrane | 1.88006074 |
| 26 | MP0002108_abnormal_muscle_morphology | 1.85108533 |
| 27 | MP0005375_adipose_tissue_phenotype | 1.83155004 |
| 28 | MP0008775_abnormal_heart_ventricle | 1.79374355 |
| 29 | MP0001756_abnormal_urination | 1.77366530 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.72454004 |
| 31 | MP0000749_muscle_degeneration | 1.66338638 |
| 32 | MP0004087_abnormal_muscle_fiber | 1.65567389 |
| 33 | MP0005275_abnormal_skin_tensile | 1.63983719 |
| 34 | MP0001661_extended_life_span | 1.59537672 |
| 35 | MP0003195_calcinosis | 1.56008490 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.54312433 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.53995305 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.51811873 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.51811196 |
| 40 | MP0005620_abnormal_muscle_contractility | 1.50269783 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.47642133 |
| 42 | MP0002136_abnormal_kidney_physiology | 1.40601771 |
| 43 | MP0001765_abnormal_ion_homeostasis | 1.37465812 |
| 44 | MP0002295_abnormal_pulmonary_circulatio | 1.37073785 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.35103085 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.32154396 |
| 47 | MP0002127_abnormal_cardiovascular_syste | 1.29371237 |
| 48 | MP0003186_abnormal_redox_activity | 1.27662895 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.27477249 |
| 50 | MP0006138_congestive_heart_failure | 1.27381500 |
| 51 | MP0000759_abnormal_skeletal_muscle | 1.25763727 |
| 52 | MP0001851_eye_inflammation | 1.25489129 |
| 53 | MP0010630_abnormal_cardiac_muscle | 1.25162820 |
| 54 | MP0009764_decreased_sensitivity_to | 1.25109617 |
| 55 | MP0005670_abnormal_white_adipose | 1.24736527 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.24528186 |
| 57 | MP0001666_abnormal_nutrient_absorption | 1.24083618 |
| 58 | MP0009115_abnormal_fat_cell | 1.23606458 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.22132052 |
| 60 | MP0002133_abnormal_respiratory_system | 1.21059936 |
| 61 | MP0005388_respiratory_system_phenotype | 1.21059936 |
| 62 | MP0000343_altered_response_to | 1.20360155 |
| 63 | MP0008995_early_reproductive_senescence | 1.18271304 |
| 64 | MP0002132_abnormal_respiratory_system | 1.17845784 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.16883549 |
| 66 | MP0004085_abnormal_heartbeat | 1.14806640 |
| 67 | MP0003690_abnormal_glial_cell | 1.13535291 |
| 68 | MP0005164_abnormal_response_to | 1.13456968 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 1.13266605 |
| 70 | MP0005595_abnormal_vascular_smooth | 1.11290672 |
| 71 | MP0002168_other_aberrant_phenotype | 1.11077162 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.09309364 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.08026586 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.08026586 |
| 75 | MP0000249_abnormal_blood_vessel | 1.07185626 |
| 76 | MP0004130_abnormal_muscle_cell | 1.05636995 |
| 77 | MP0000767_abnormal_smooth_muscle | 1.05521925 |
| 78 | MP0000609_abnormal_liver_physiology | 1.03121753 |
| 79 | MP0003646_muscle_fatigue | 1.02929052 |
| 80 | MP0005369_muscle_phenotype | 1.02411561 |
| 81 | MP0002269_muscular_atrophy | 1.02310883 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 1.02236129 |
| 83 | MP0003137_abnormal_impulse_conducting | 1.00980079 |
| 84 | MP0009840_abnormal_foam_cell | 1.00774146 |
| 85 | MP0009780_abnormal_chondrocyte_physiolo | 1.00703296 |
| 86 | MP0003828_pulmonary_edema | 1.00444520 |
| 87 | MP0005165_increased_susceptibility_to | 1.00318768 |
| 88 | MP0004883_abnormal_blood_vessel | 1.00099733 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99738088 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.98479812 |
| 91 | MP0000747_muscle_weakness | 0.93725375 |
| 92 | MP0002254_reproductive_system_inflammat | 0.93596015 |
| 93 | MP0005385_cardiovascular_system_phenoty | 0.92934663 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 0.92934663 |
| 95 | MP0005408_hypopigmentation | 0.91664480 |
| 96 | MP0002928_abnormal_bile_duct | 0.89802278 |
| 97 | MP0005334_abnormal_fat_pad | 0.89177376 |
| 98 | MP0006054_spinal_hemorrhage | 0.88948168 |
| 99 | MP0003279_aneurysm | 0.87294918 |
| 100 | MP0001177_atelectasis | 0.86524917 |
| 101 | MP0002933_joint_inflammation | 0.86174613 |
| 102 | MP0004084_abnormal_cardiac_muscle | 0.84004138 |
| 103 | MP0005647_abnormal_sex_gland | 0.83087479 |
| 104 | MP0008004_abnormal_stomach_pH | 0.82643439 |
| 105 | MP0002796_impaired_skin_barrier | 0.82484239 |
| 106 | MP0009278_abnormal_bone_marrow | 0.81206623 |
| 107 | MP0002106_abnormal_muscle_physiology | 0.81146961 |
| 108 | MP0003075_altered_response_to | 0.79226997 |
| 109 | MP0000534_abnormal_ureter_morphology | 0.79105905 |
| 110 | MP0000465_gastrointestinal_hemorrhage | 0.78268574 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.78124976 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.76288047 |
| 113 | MP0005535_abnormal_body_temperature | 0.76118649 |
| 114 | MP0004510_myositis | 0.75769548 |
| 115 | MP0002135_abnormal_kidney_morphology | 0.75233032 |
| 116 | MP0002837_dystrophic_cardiac_calcinosis | 0.74924757 |
| 117 | MP0005023_abnormal_wound_healing | 0.74087161 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.72484534 |
| 119 | MP0001614_abnormal_blood_vessel | 0.71963148 |
| 120 | MP0003959_abnormal_lean_body | 0.70380641 |
| 121 | MP0000750_abnormal_muscle_regeneration | 0.68893777 |
| 122 | MP0000537_abnormal_urethra_morphology | 0.66727362 |
| 123 | MP0004036_abnormal_muscle_relaxation | 0.66043269 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.65952619 |
| 125 | MP0005220_abnormal_exocrine_pancreas | 0.65866891 |
| 126 | MP0005508_abnormal_skeleton_morphology | 0.65819499 |
| 127 | MP0004484_altered_response_of | 0.65634710 |
| 128 | MP0000681_abnormal_thyroid_gland | 0.65466335 |
| 129 | MP0001501_abnormal_sleep_pattern | 0.65322935 |
| 130 | MP0003045_fibrosis | 0.65253765 |
| 131 | MP0002128_abnormal_blood_circulation | 0.65206416 |
| 132 | MP0002332_abnormal_exercise_endurance | 0.64316553 |
| 133 | MP0001175_abnormal_lung_morphology | 0.63138473 |
| 134 | MP0005166_decreased_susceptibility_to | 0.62587966 |
| 135 | MP0000266_abnormal_heart_morphology | 0.61898242 |
| 136 | MP0005330_cardiomyopathy | 0.61228843 |
| 137 | MP0002925_abnormal_cardiovascular_devel | 0.60295983 |
| 138 | MP0002972_abnormal_cardiac_muscle | 0.58137863 |
| 139 | MP0002971_abnormal_brown_adipose | 0.57779696 |
| 140 | MP0005376_homeostasis/metabolism_phenot | 0.57297146 |
| 141 | MP0004147_increased_porphyrin_level | 0.57279633 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.56910565 |
| 143 | MP0000598_abnormal_liver_morphology | 0.55424831 |
| 144 | MP0001270_distended_abdomen | 0.54842422 |
| 145 | MP0008469_abnormal_protein_level | 0.53542790 |
| 146 | MP0009642_abnormal_blood_homeostasis | 0.53408214 |
| 147 | MP0003091_abnormal_cell_migration | 0.52720875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 6.42794753 |
| 2 | Polycythemia (HP:0001901) | 5.04960308 |
| 3 | Gout (HP:0001997) | 5.01464355 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 4.44332346 |
| 5 | Renal salt wasting (HP:0000127) | 4.16946037 |
| 6 | Interstitial pulmonary disease (HP:0006530) | 4.09529921 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.02313821 |
| 8 | Hematochezia (HP:0002573) | 4.01223353 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 3.92694259 |
| 10 | Sudden death (HP:0001699) | 3.92641184 |
| 11 | Esophageal varix (HP:0002040) | 3.87802962 |
| 12 | Facial shape deformation (HP:0011334) | 3.85152203 |
| 13 | Potter facies (HP:0002009) | 3.85152203 |
| 14 | Abnormality of chloride homeostasis (HP:0011422) | 3.84868530 |
| 15 | Spontaneous hematomas (HP:0007420) | 3.73463414 |
| 16 | Hyperaldosteronism (HP:0000859) | 3.66040392 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 3.54165126 |
| 18 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.53924211 |
| 19 | Vascular calcification (HP:0004934) | 3.48799632 |
| 20 | Abnormality of purine metabolism (HP:0004352) | 3.46330721 |
| 21 | Increased variability in muscle fiber diameter (HP:0003557) | 3.43797923 |
| 22 | Abnormal ciliary motility (HP:0012262) | 3.42345913 |
| 23 | Hyperkalemia (HP:0002153) | 3.42277203 |
| 24 | Tubulointerstitial fibrosis (HP:0005576) | 3.40404380 |
| 25 | Increased connective tissue (HP:0009025) | 3.37991825 |
| 26 | Vascular tortuosity (HP:0004948) | 3.37758953 |
| 27 | Hyperglycinuria (HP:0003108) | 3.37478192 |
| 28 | Rhinitis (HP:0012384) | 3.33799493 |
| 29 | Cardiovascular calcification (HP:0011915) | 3.33378804 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 3.31648793 |
| 31 | Exercise-induced myalgia (HP:0003738) | 3.31572173 |
| 32 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.27286161 |
| 33 | Absent/shortened dynein arms (HP:0200106) | 3.27286161 |
| 34 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.21313596 |
| 35 | Hyperuricemia (HP:0002149) | 3.19646884 |
| 36 | Increased purine levels (HP:0004368) | 3.19646884 |
| 37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.19432095 |
| 38 | Distal lower limb muscle weakness (HP:0009053) | 3.17785020 |
| 39 | Asymmetric septal hypertrophy (HP:0001670) | 3.17065958 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.14610482 |
| 41 | Glomerulonephritis (HP:0000099) | 3.07318668 |
| 42 | Arterial tortuosity (HP:0005116) | 3.06644336 |
| 43 | Type 1 muscle fiber predominance (HP:0003803) | 3.04916539 |
| 44 | Visceral angiomatosis (HP:0100761) | 3.04857755 |
| 45 | Increased circulating renin level (HP:0000848) | 3.03879719 |
| 46 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.00409164 |
| 47 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.00409164 |
| 48 | Alkalosis (HP:0001948) | 2.98994300 |
| 49 | Ventricular tachycardia (HP:0004756) | 2.98081891 |
| 50 | Lipoatrophy (HP:0100578) | 2.97466563 |
| 51 | Metabolic alkalosis (HP:0200114) | 2.95756002 |
| 52 | Atrial fibrillation (HP:0005110) | 2.93593139 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.92954874 |
| 54 | Abnormality of renal excretion (HP:0011036) | 2.91959722 |
| 55 | Neck muscle weakness (HP:0000467) | 2.90809654 |
| 56 | Chronic bronchitis (HP:0004469) | 2.89861962 |
| 57 | Bundle branch block (HP:0011710) | 2.89614493 |
| 58 | Abnormality of the calf musculature (HP:0001430) | 2.88912081 |
| 59 | Ketoacidosis (HP:0001993) | 2.84003380 |
| 60 | Hemangiomatosis (HP:0007461) | 2.80437148 |
| 61 | Pulmonary artery stenosis (HP:0004415) | 2.79234397 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.79151824 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.79151824 |
| 64 | EMG: myopathic abnormalities (HP:0003458) | 2.76965693 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.76317364 |
| 66 | Cerebral hemorrhage (HP:0001342) | 2.75954991 |
| 67 | Abnormality of the fingertips (HP:0001211) | 2.75640705 |
| 68 | Abnormal urine output (HP:0012590) | 2.75619694 |
| 69 | Right ventricular cardiomyopathy (HP:0011663) | 2.75554323 |
| 70 | Proximal tubulopathy (HP:0000114) | 2.73402860 |
| 71 | Tachypnea (HP:0002789) | 2.73018132 |
| 72 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.72484666 |
| 73 | Complement deficiency (HP:0004431) | 2.72349246 |
| 74 | Ketosis (HP:0001946) | 2.72109408 |
| 75 | Frequent falls (HP:0002359) | 2.69302784 |
| 76 | Xanthomatosis (HP:0000991) | 2.67117374 |
| 77 | Intrahepatic cholestasis (HP:0001406) | 2.65471250 |
| 78 | Growth hormone excess (HP:0000845) | 2.65014400 |
| 79 | Primary atrial arrhythmia (HP:0001692) | 2.62348497 |
| 80 | Acanthosis nigricans (HP:0000956) | 2.57340351 |
| 81 | Spinal rigidity (HP:0003306) | 2.56812764 |
| 82 | Atrioventricular block (HP:0001678) | 2.55482599 |
| 83 | Protrusio acetabuli (HP:0003179) | 2.55029099 |
| 84 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.53048323 |
| 85 | Syncope (HP:0001279) | 2.50647595 |
| 86 | Difficulty running (HP:0009046) | 2.48525972 |
| 87 | Supraventricular tachycardia (HP:0004755) | 2.46819681 |
| 88 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46308947 |
| 89 | Hyperammonemia (HP:0001987) | 2.43931479 |
| 90 | Supraventricular arrhythmia (HP:0005115) | 2.43665814 |
| 91 | Scapular winging (HP:0003691) | 2.42540582 |
| 92 | Aortic dissection (HP:0002647) | 2.42049850 |
| 93 | Hypomagnesemia (HP:0002917) | 2.41776772 |
| 94 | Muscle fiber inclusion bodies (HP:0100299) | 2.39004477 |
| 95 | Conjunctival telangiectasia (HP:0000524) | 2.38718695 |
| 96 | Abnormality of potassium homeostasis (HP:0011042) | 2.35801847 |
| 97 | Abnormal atrioventricular conduction (HP:0005150) | 2.35490394 |
| 98 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.33875799 |
| 99 | Decreased circulating renin level (HP:0003351) | 2.33042347 |
| 100 | Aortic aneurysm (HP:0004942) | 2.32403895 |
| 101 | Skin nodule (HP:0200036) | 2.31107135 |
| 102 | Dilated cardiomyopathy (HP:0001644) | 2.30083172 |
| 103 | Aneurysm (HP:0002617) | 2.30003910 |
| 104 | Polyuria (HP:0000103) | 2.29477612 |
| 105 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.29400561 |
| 106 | Heart block (HP:0012722) | 2.27463166 |
| 107 | Foot dorsiflexor weakness (HP:0009027) | 2.25141900 |
| 108 | Pulmonary hypertension (HP:0002092) | 2.24354208 |
| 109 | Oligomenorrhea (HP:0000876) | 2.24200670 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 2.23941320 |
| 111 | Hydroxyprolinuria (HP:0003080) | 2.23941320 |
| 112 | Abnormality of the foot musculature (HP:0001436) | 2.23102262 |
| 113 | Hypotension (HP:0002615) | 2.22251975 |
| 114 | Cavernous hemangioma (HP:0001048) | 2.21960989 |
| 115 | Striae distensae (HP:0001065) | 2.21942093 |
| 116 | Hypoglycemic coma (HP:0001325) | 2.21708275 |
| 117 | Ventricular fibrillation (HP:0001663) | 2.21401765 |
| 118 | Nephrolithiasis (HP:0000787) | 2.15822948 |
| 119 | Alveolar cell carcinoma (HP:0006519) | 2.15506377 |
| 120 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.14508692 |
| 121 | Rimmed vacuoles (HP:0003805) | 2.12994588 |
| 122 | Long toe (HP:0010511) | 2.12485173 |
| 123 | Neonatal death (HP:0003811) | 2.12478532 |
| 124 | Respiratory distress (HP:0002098) | 2.11761662 |
| 125 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10982685 |
| 126 | Osteolytic defects of the hand bones (HP:0009699) | 2.10982685 |
| 127 | Metabolic acidosis (HP:0001942) | 2.10813925 |
| 128 | Hypokalemia (HP:0002900) | 2.10383962 |
| 129 | Proximal amyotrophy (HP:0007126) | 2.10149738 |
| 130 | Ventricular arrhythmia (HP:0004308) | 2.09892671 |
| 131 | Nasal polyposis (HP:0100582) | 2.09752358 |
| 132 | Hypertriglyceridemia (HP:0002155) | 2.08941353 |
| 133 | Broad metatarsal (HP:0001783) | 2.08154856 |
| 134 | Joint hemorrhage (HP:0005261) | 2.07959504 |
| 135 | Hyperglycinemia (HP:0002154) | 2.07503193 |
| 136 | Tetany (HP:0001281) | 2.07177622 |
| 137 | Glucose intolerance (HP:0000833) | 2.06583638 |
| 138 | Bronchiectasis (HP:0002110) | 2.04060130 |
| 139 | Tubulointerstitial abnormality (HP:0001969) | 2.03616663 |
| 140 | Nemaline bodies (HP:0003798) | 2.03480286 |
| 141 | Dehydration (HP:0001944) | 2.03374120 |
| 142 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01244906 |
| 143 | Myocardial infarction (HP:0001658) | 2.00787694 |
| 144 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.00060606 |
| 145 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.99228017 |
| 146 | Delayed CNS myelination (HP:0002188) | 1.97890119 |
| 147 | Abnormal cartilage morphology (HP:0002763) | 1.96932324 |
| 148 | Hypercortisolism (HP:0001578) | 1.96029973 |
| 149 | Mitral stenosis (HP:0001718) | 1.95947601 |
| 150 | Bell-shaped thorax (HP:0001591) | 1.95939145 |
| 151 | Hyponatremia (HP:0002902) | 1.95732227 |
| 152 | Lymphangioma (HP:0100764) | 1.95508872 |
| 153 | Steppage gait (HP:0003376) | 1.94919685 |
| 154 | Cerebral palsy (HP:0100021) | 1.94135112 |
| 155 | Malnutrition (HP:0004395) | 1.92809656 |
| 156 | Calf muscle hypertrophy (HP:0008981) | 1.92662287 |
| 157 | Chondrocalcinosis (HP:0000934) | 1.92122289 |
| 158 | Axonal loss (HP:0003447) | 1.90951008 |
| 159 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.90869818 |
| 160 | Abnormality of magnesium homeostasis (HP:0004921) | 1.90843783 |
| 161 | Prolonged QT interval (HP:0001657) | 1.90160919 |
| 162 | Glycosuria (HP:0003076) | 1.90133692 |
| 163 | Abnormality of urine glucose concentration (HP:0011016) | 1.90133692 |
| 164 | Fat malabsorption (HP:0002630) | 1.89469183 |
| 165 | Portal hypertension (HP:0001409) | 1.87601034 |
| 166 | Hypoalphalipoproteinemia (HP:0003233) | 1.87101683 |
| 167 | Cerebral aneurysm (HP:0004944) | 1.87044943 |
| 168 | Shawl scrotum (HP:0000049) | 1.86780618 |
| 169 | Systemic lupus erythematosus (HP:0002725) | 1.86670857 |
| 170 | Abnormality of complement system (HP:0005339) | 1.86408186 |
| 171 | Nephritis (HP:0000123) | 1.85323284 |
| 172 | Hyperlipoproteinemia (HP:0010980) | 1.83868563 |
| 173 | Amyloidosis (HP:0011034) | 1.82968841 |
| 174 | Muscle fiber splitting (HP:0003555) | 1.82819806 |
| 175 | Bronchitis (HP:0012387) | 1.77488752 |
| 176 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77125324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 7.60935775 |
| 2 | TGFBR2 | 3.65143023 |
| 3 | WNK4 | 2.51981529 |
| 4 | MYLK | 2.49841809 |
| 5 | RIPK1 | 2.41096854 |
| 6 | FGFR4 | 2.35742068 |
| 7 | BCKDK | 2.26308959 |
| 8 | MAP3K3 | 2.19082661 |
| 9 | ERN1 | 2.10642948 |
| 10 | OXSR1 | 2.07689170 |
| 11 | EPHB1 | 2.07108346 |
| 12 | TTN | 1.95908025 |
| 13 | FER | 1.80840948 |
| 14 | EPHB2 | 1.78688925 |
| 15 | CDC42BPA | 1.78032899 |
| 16 | WNK3 | 1.77893643 |
| 17 | MAP3K6 | 1.72984608 |
| 18 | TRIB3 | 1.70610405 |
| 19 | NLK | 1.57929066 |
| 20 | MAPKAPK3 | 1.55243227 |
| 21 | GRK1 | 1.50254576 |
| 22 | LRRK2 | 1.50122903 |
| 23 | MAP3K2 | 1.46733177 |
| 24 | LATS2 | 1.46309544 |
| 25 | MAP3K13 | 1.45405820 |
| 26 | PTK6 | 1.43552218 |
| 27 | MST1R | 1.41878376 |
| 28 | MST4 | 1.41241560 |
| 29 | KDR | 1.40226089 |
| 30 | MAP2K3 | 1.29179879 |
| 31 | PDK2 | 1.26605087 |
| 32 | LMTK2 | 1.26267669 |
| 33 | PAK4 | 1.26096589 |
| 34 | AKT3 | 1.24970413 |
| 35 | FGFR2 | 1.22286363 |
| 36 | TGFBR1 | 1.19005684 |
| 37 | EEF2K | 1.17617540 |
| 38 | CSK | 1.15369034 |
| 39 | MAP3K7 | 1.11677761 |
| 40 | STK39 | 1.09726329 |
| 41 | PDGFRA | 1.09029440 |
| 42 | MAPK7 | 1.08066025 |
| 43 | SIK1 | 1.04536682 |
| 44 | PDK3 | 1.03468856 |
| 45 | PDK4 | 1.03468856 |
| 46 | LATS1 | 1.01719293 |
| 47 | EPHA3 | 1.01332777 |
| 48 | FRK | 1.00404104 |
| 49 | MAPK15 | 0.99155489 |
| 50 | STK38L | 0.98826277 |
| 51 | PAK3 | 0.98808773 |
| 52 | INSRR | 0.98676617 |
| 53 | MOS | 0.97191229 |
| 54 | MAP2K2 | 0.94416146 |
| 55 | MAPK4 | 0.93828235 |
| 56 | STK10 | 0.92682395 |
| 57 | GSK3A | 0.91192453 |
| 58 | FGFR3 | 0.89525179 |
| 59 | SGK494 | 0.86926286 |
| 60 | SGK223 | 0.86926286 |
| 61 | PTK2 | 0.86506574 |
| 62 | GRK5 | 0.86045902 |
| 63 | SGK3 | 0.85539350 |
| 64 | KIT | 0.84218412 |
| 65 | PDPK1 | 0.83670086 |
| 66 | ILK | 0.81233026 |
| 67 | PTK2B | 0.78803001 |
| 68 | BLK | 0.78310501 |
| 69 | MUSK | 0.78010184 |
| 70 | DMPK | 0.76777673 |
| 71 | PRKD1 | 0.76105760 |
| 72 | NEK9 | 0.72498465 |
| 73 | CAMK1D | 0.71924634 |
| 74 | DAPK2 | 0.71917113 |
| 75 | SGK2 | 0.71842639 |
| 76 | DAPK3 | 0.71537714 |
| 77 | MET | 0.69478562 |
| 78 | PKN2 | 0.66927879 |
| 79 | EPHA2 | 0.66631562 |
| 80 | TYK2 | 0.66432884 |
| 81 | JAK1 | 0.65399769 |
| 82 | TEC | 0.64003449 |
| 83 | STK38 | 0.62280366 |
| 84 | RET | 0.62251934 |
| 85 | PRKG1 | 0.60225138 |
| 86 | PRKCH | 0.59047696 |
| 87 | PDGFRB | 0.57254712 |
| 88 | PRPF4B | 0.56315931 |
| 89 | GRK7 | 0.55421922 |
| 90 | MTOR | 0.54684901 |
| 91 | CAMK1 | 0.53912795 |
| 92 | PINK1 | 0.51395861 |
| 93 | JAK2 | 0.50636107 |
| 94 | ROCK2 | 0.50323615 |
| 95 | PRKAA2 | 0.49343009 |
| 96 | CAMK4 | 0.46867571 |
| 97 | NEK1 | 0.46856652 |
| 98 | MARK3 | 0.46136523 |
| 99 | MAP2K1 | 0.45489420 |
| 100 | IRAK1 | 0.45023272 |
| 101 | STK24 | 0.44652123 |
| 102 | TBK1 | 0.44483075 |
| 103 | ARAF | 0.44119751 |
| 104 | PHKG1 | 0.43653151 |
| 105 | PHKG2 | 0.43653151 |
| 106 | PRKACG | 0.42736738 |
| 107 | ZAP70 | 0.42377366 |
| 108 | DDR2 | 0.41845592 |
| 109 | WNK1 | 0.41734935 |
| 110 | PRKACB | 0.41719245 |
| 111 | PIK3CG | 0.41568801 |
| 112 | PRKCE | 0.41231926 |
| 113 | PAK2 | 0.41139944 |
| 114 | PRKAA1 | 0.40612760 |
| 115 | ABL2 | 0.39641720 |
| 116 | RPS6KA2 | 0.39543564 |
| 117 | RPS6KC1 | 0.39379706 |
| 118 | RPS6KL1 | 0.39379706 |
| 119 | CDK6 | 0.39040046 |
| 120 | MAPK12 | 0.38927059 |
| 121 | ROCK1 | 0.38896035 |
| 122 | PIK3CA | 0.37471022 |
| 123 | CAMK1G | 0.37035409 |
| 124 | TRPM7 | 0.35594305 |
| 125 | OBSCN | 0.35584622 |
| 126 | IKBKE | 0.34910179 |
| 127 | MAP3K1 | 0.34882387 |
| 128 | EGFR | 0.34732068 |
| 129 | MAP3K14 | 0.33539537 |
| 130 | STK3 | 0.33011268 |
| 131 | MARK2 | 0.32715903 |
| 132 | BMX | 0.31903402 |
| 133 | TESK1 | 0.31821714 |
| 134 | TAOK3 | 0.30936496 |
| 135 | HIPK2 | 0.28640992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41966397 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.76592402 |
| 3 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71888998 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68904625 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.60904579 |
| 6 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.50419871 |
| 7 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.49398691 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.46367637 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.32150377 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.26810100 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16758925 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.04383394 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02559230 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.99865604 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.98539047 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89536331 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.86662800 |
| 18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85564916 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85381093 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.82739979 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.76814562 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75384269 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73291860 |
| 24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.67709766 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62376183 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61481567 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61379661 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60913563 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.57993589 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.57602600 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55404640 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49467120 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47753104 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46610147 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.41604347 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37173183 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.32165178 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.30136729 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23482726 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20317185 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13059518 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05213216 |
| 43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00189696 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 0.99424048 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97051086 |
| 46 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.95655153 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93403905 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92797533 |
| 49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92510131 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.91823753 |
| 51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90904728 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90105262 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88640299 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86474770 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86455027 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.84403146 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.84077784 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82675388 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81038303 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80942371 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80763229 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79984963 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79828685 |
| 64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79442548 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78585756 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74629693 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.71755138 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.68550355 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67437515 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67410877 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 0.67046284 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66547339 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65802133 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65505396 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63681875 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63087501 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62434318 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.62421229 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62420858 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61538283 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61496913 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58015943 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.56516642 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56214395 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55564926 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.55500333 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52826974 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51657416 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.51539509 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50658099 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.50174684 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49422135 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49015390 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48007135 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47146947 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46660603 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46459021 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43756870 |
| 99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43429212 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43069247 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41454524 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41243675 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41222017 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41177255 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40869359 |
| 106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40414138 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38102844 |
| 108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37741462 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37550861 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37011246 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.35270689 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35263273 |
| 113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35117384 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34841793 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.34177669 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33442068 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.32532757 |
| 118 | Malaria_Homo sapiens_hsa05144 | 0.31095487 |
| 119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.30872631 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29889428 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29784353 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.29365990 |
| 123 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.29223610 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28150924 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27248563 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25957756 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25580231 |
| 128 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.23022451 |
| 129 | Renin secretion_Homo sapiens_hsa04924 | 0.22990758 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.21612380 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.20798016 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20603932 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19602801 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19136135 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.18904791 |
| 136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17953016 |
| 137 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.17724013 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17421539 |
| 139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15816701 |
| 140 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15237805 |

